Imidazole based LXR modulators

Details for Australian Patent Application No. 2006261845 (hide)

Owner Exelixis Patent Company LLC

Inventors Stevens, William C. Jr.; Gu, Xiao-Hui; Xie, Yinong; Mohan, Raju; Schweiger, Edwin; Flatt, Brenton T.; Wang, Tie-Lin; Lu, Shao-Po; Martin, Richard; Nyman, Michael Charles; Busch, Brett B.

Agent Davies Collison Cave

Pub. Number AU-B-2006261845

PCT Pub. Number WO2007/002563

Priority 60/736,120 10.11.05 US; 60/694,372 27.06.05 US

Filing date 26 June 2006

Wipo publication date 4 January 2007

Acceptance publication date 13 September 2012

International Classifications

C07D 233/54 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4164 - 1,3-Diazoles

A61P 3/10 Drugs for disorders of the metabolism

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

C07D 409/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/002563 Priority application(s): WO2007/002563

22 March 2012 Assignment before Grant

  Exelixis, Inc. The application has been assigned to Exelixis Patent Company LLC

13 September 2012 Application Accepted

  Published as AU-B-2006261845

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261848-Transparent or translucent conditioning composition packed into transparent and/or translucent container

2006261843-Tissue repair